AU2001251414A1 - Method of detecting carcinomas - Google Patents

Method of detecting carcinomas

Info

Publication number
AU2001251414A1
AU2001251414A1 AU2001251414A AU5141401A AU2001251414A1 AU 2001251414 A1 AU2001251414 A1 AU 2001251414A1 AU 2001251414 A AU2001251414 A AU 2001251414A AU 5141401 A AU5141401 A AU 5141401A AU 2001251414 A1 AU2001251414 A1 AU 2001251414A1
Authority
AU
Australia
Prior art keywords
detecting carcinomas
carcinomas
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251414A
Inventor
Timothy R. Compton
James R. Erickson
Jeff A. Parrott
Robert L. Wolfert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atairgin Technologies Inc
Original Assignee
Atairgin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atairgin Technologies Inc filed Critical Atairgin Technologies Inc
Publication of AU2001251414A1 publication Critical patent/AU2001251414A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001251414A 2000-04-26 2001-04-06 Method of detecting carcinomas Abandoned AU2001251414A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/558,880 US6500633B1 (en) 2000-04-26 2000-04-26 Method of detecting carcinomas
US09558880 2000-04-26
PCT/US2001/011317 WO2001081362A1 (en) 2000-04-26 2001-04-06 Method of detecting carcinomas

Publications (1)

Publication Number Publication Date
AU2001251414A1 true AU2001251414A1 (en) 2001-11-07

Family

ID=24231363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251414A Abandoned AU2001251414A1 (en) 2000-04-26 2001-04-06 Method of detecting carcinomas

Country Status (3)

Country Link
US (1) US6500633B1 (en)
AU (1) AU2001251414A1 (en)
WO (1) WO2001081362A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8594942B2 (en) * 2004-07-30 2013-11-26 Metabolon, Inc. Computational method and system for identifying network patterns in complex biological systems data
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7491504B2 (en) 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US9217749B2 (en) * 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
US8796429B2 (en) * 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9274129B2 (en) * 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US20080213768A1 (en) * 2006-08-17 2008-09-04 Zhauhui Cai Identification and use of biomarkers for non-invasive and early detection of liver injury
EP2082218A2 (en) * 2006-10-03 2009-07-29 Oklahoma Medical Research Foundation Metabolite detection using magnetic resonance
US20100291690A1 (en) * 2007-11-07 2010-11-18 Lian Shan Methods for detecting or monitoring cancer using lpc as a marker
WO2009061404A1 (en) * 2007-11-07 2009-05-14 Frantz Biomarkers, Llc Methods for detecting or monitoring cancer using lpc as a marker
WO2012103787A1 (en) * 2011-02-01 2012-08-09 The University Of Hongkong Use of anti-dkk1 monoclonal antibody for treatment of liver cancer
EP2686347B1 (en) 2011-03-16 2018-05-02 argenx BVBA Antibodies to cd70
JO3283B1 (en) 2011-04-26 2018-09-16 Sanofi Sa Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
JP5872285B2 (en) * 2011-12-28 2016-03-01 株式会社島津製作所 Renal cancer blood marker
KR101890885B1 (en) * 2013-02-15 2018-08-22 토마스 제퍼슨 유니버시티 Method for detecting shed or circulating tumor cells in biological fluids
EA035674B1 (en) 2014-07-18 2020-07-24 Санофи Method of determining whether a patient suspected to suffer from cancer is a candidate for aflibercept therapy
US10391168B1 (en) 2014-08-22 2019-08-27 University Of Bern Anti-CD70 combination therapy
JP6900314B2 (en) * 2014-12-24 2021-07-07 ジェネンテック， インコーポレイテッド Treatment, diagnosis, and prognosis of bladder cancer
WO2017129537A1 (en) * 2016-01-25 2017-08-03 Sanofi Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer by measuring the level of a plasma biomarker
GB201800649D0 (en) 2018-01-16 2018-02-28 Argenx Bvba CD70 Combination Therapy
UY38511A (en) 2018-12-18 2020-07-31 Argenx Bvba COMBINATION THERAPY CD70

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55118419A (en) 1979-03-05 1980-09-11 Toyama Chem Co Ltd Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same
DE3231288C2 (en) * 1982-08-23 1984-06-28 MEDI-PHARMA Vertriebsgesellschaft mbH, 5000 Köln Diagnostic device and its use
JPS59140900A (en) 1983-01-28 1984-08-13 Toyo Jozo Co Ltd Novel method for highly sensitive, enzymatic determination
US4698299A (en) 1985-02-19 1987-10-06 The Liposome Company, Inc. Lipid-dependent diagnostic assays
JPS63233800A (en) 1987-03-20 1988-09-29 Toyo Jozo Co Ltd Method for measuring activity of lecithin cholesterol acyltransferase
JP2872256B2 (en) 1987-08-27 1999-03-17 イーライ リリー アンド カンパニー Synovial membrane phospholipase
FR2623508B1 (en) 1987-11-20 1990-04-20 Commissariat Energie Atomique BASIC PROTEIN NAMED PHOSPHOLIPASE A2 ISOLATED FROM SNAP VENOM OF THE ELAPID FAMILY AND ITS AMINO ACID SEQUENCE, DERIVATIVES AND FRAGMENTS OF THE SAME, PROCESS FOR OBTAINING THERAPEUTIC COMPOSITIONS, AND DIAGNOSTIC AGENTS CONTAINING SAME AND / OR ITS FRAGMENTS
JP2707642B2 (en) 1988-10-15 1998-02-04 日本油脂株式会社 Method for producing lysophospholipid
JPH04503957A (en) 1989-03-07 1992-07-16 ジェネンテク，インコーポレイテッド Covalent conjugates of lipids and oligonucleotides
JPH07121953B2 (en) 1991-11-30 1995-12-25 株式會社眞露 Novel pyrrolidine derivatives and salts thereof, process for producing the same, medicinal composition and preparation for transdermal administration
US5489580A (en) 1992-11-05 1996-02-06 University Of Connecticut Phospholipid compounds and use therefor
US5277917A (en) 1993-04-02 1994-01-11 Allelix Biopharmaceuticals Inc. Ovarian cancer ascites factor, in isolated form
JPH0853475A (en) 1994-08-11 1996-02-27 Daiichi Rajio Isotope Kenkyusho:Kk Phospholipid compound containing radioactive iodine-labeled boron
US5824555A (en) * 1996-05-30 1998-10-20 The Cleveland Clinic Foundation Method of detecting gynecological carcinomas
US6248553B1 (en) * 1998-10-22 2001-06-19 Atairgin Technologies, Inc. Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids
CA2389832A1 (en) 1999-11-04 2001-05-10 Abbott Laboratories Improved automated lpa assay and methods of detecting cancer

Also Published As

Publication number Publication date
US6500633B1 (en) 2002-12-31
WO2001081362A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
AU2001251414A1 (en) Method of detecting carcinomas
AU2001276484A1 (en) Drilling method
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AUPQ687600A0 (en) A method of detection
AU2002346008A1 (en) Method for detection of melanoma
AU6364699A (en) Detection of analytes
AU2002210881A1 (en) Transdermal method
AU2001281633A1 (en) Detection method
AU2001268701A1 (en) Methods of enhancing adhesion
AUPR050700A0 (en) Detection method
AUPQ667800A0 (en) Detection method
AU5867901A (en) Method for detecting tumors
AU5650401A (en) Method for enhancing cognitive function
AU2001237530A1 (en) Method
AU2001260716A1 (en) Method of detecting saccharified albumin
AU2002221104A1 (en) Method of detecting relation between genes
AU2001241636A1 (en) Halotherapy method
AU2001246862A1 (en) Method of detecting cancer
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001264000A1 (en) Phosphomagnesium mortar and method for obtaining same
AU2001232231A1 (en) Method for detecting substance
AUPQ639300A0 (en) Method of enhancing or maintaining a relationship
AUPQ781100A0 (en) A method of detection
AUPQ677300A0 (en) Detection method
AU2001286268A1 (en) Method of forming complex